000 03666nam a2200433 c 4500
999 _c118001
_d118001
001 118001
003 ES-MaUEC
005 20230102113838.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 191130s2019 gw a o |||| 0|eng d
020 _a9783030291082
024 7 _a10.1007/978-3-030-29108-2
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC606.6
_bH583 2019
245 0 0 _aHIV and Tuberculosis
_bA Formidable Alliance
_cedited by Irini Sereti, Gregory P. Bisson, Graeme Meintjes.
250 _aFirst edition
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2019
300 _a1 recurso en línea (X, 347 páginas)
_b32 ilustraciones, 23 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _a1. Overview of the HIV-associated tuberculosis epidemic -- 2 . Epidemiology of Drug-susceptible, Drug-resistant Tuberculosis and HIV in Africa -- 3. Modelling the HIV-associated TB epidemic and the impact of interventions aimed at epidemic control -- 4. Immune responses to Mycobacterium tuberculosis and the impact of HIV infection -- 5. Clinical Manifestations of HIV-associated tuberculosis in adults -- 6. The tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) -- 7. Diagnosis of HIV-associated tuberculosis -- 8. Recent advances in the treatment of latent tuberculosis infection among adults living with HIV -- 9. Treatment of drug-sensitive tuberculosis in persons with HIV -- 10. Drug-resistant TB and HIV -- 11. Co-treatment of tuberculosis and HIV: pharmacologic considerations -- 12. HIV and TB in children -- 13. Neurological TB in HIV.
520 3 _aGlobally, HIV-associated tuberculosis is one of the most important causes of infection-related death, accounting for over 300,000 deaths worldwide in 2017. The HIV epidemic has undermined TB control efforts in many countries across the world, as the virus has important modifying effects on the pathogenesis, diagnosis, and treatment of TB. The management of HIV-associated TB is also complicated by rapid clinical progression, immune reconstitution inflammatory syndrome, drug-drug interactions, and shared toxicities. The past two decades have yielded thousands of research publications and review articles on HIV-associated TB. HIV and Tuberculosis: A Formidable Alliance consolidates this massive amount of data into a single resource. With contributions from myriad disciplines, including epidemiology, immunology, public health, and clinical medicine, this book provides well-rounded and thorough coverage that will appeal to researchers and clinicians alike.
988 _aPrimersemestre_2020_BiomedLife
650 7 _2embne
_9154434
_aInfecciones por VIH
700 1 _aSereti, Irini
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBisson, Gregory P
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aMeintjes, Graeme
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106996
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783030291075
776 0 8 _iPrinted edition:
_z9783030291099
776 0 8 _iPrinted edition:
_z9783030291105
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-29108-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0